We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$412M
1-Year Est. Return
18.33%
This Fund
S&P 500
This Quarter
Est. Return
+11.98%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$1.51B
AUM Growth
+$79.8M
(+5.6%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-3.88%
Top 10 Holdings %
Top 10 Hldgs %
27.14%
Holding
456
New
26
Increased
163
Reduced
145
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Therapeutics
UTHR
|
+$17.1M |
| 2 |
Take-Two Interactive
TTWO
|
+$15.5M |
| 3 |
Las Vegas Sands
LVS
|
+$12.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.3M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EA
Electronic Arts
EA
|
+$18.8M |
| 2 |
Becton Dickinson
BDX
|
+$18.6M |
| 3 |
Franco-Nevada
FNV
|
+$13.2M |
| 4 |
Biogen
BIIB
|
+$11.5M |
| 5 |
Eversource Energy
ES
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.57% |
| 2 | Consumer Staples | 28.33% |
| 3 | Technology | 7.15% |
| 4 | Communication Services | 6.29% |
| 5 | Materials | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verizon
VZ
$208B
| $21.8M | 1.44% |
552,890
+29,511
| +6% | +$1.11M |
|
|
27
Biogen
BIIB
$32.6B
| $21.7M | 1.44% |
78,510
-40,554
| -34% | -$11.5M |
|
|
28
Bristol-Myers Squibb
BMY
$136B
| $20.9M | 1.39% |
291,100
+160,303
| +123% | +$12.1M |
|
|
29
Las Vegas Sands
LVS
$28.7B
| $20.7M | 1.37% |
430,746
+290,326
| +207% | +$12.3M |
|
30
Agnico Eagle Mines
AEM
$104B
| $20.1M | 1.33% |
385,179
-91,105
| -19% | -$4.3M |
|
31
Humana
HUM
$48.2B
| $19.6M | 1.3% |
38,270
+22,872
| +149% | +$12M |
|
32
Baxter International
BAX
$13.4B
| $19.3M | 1.28% |
379,453
-117,781
| -24% | -$6.33M |
|
33
Cboe Global Markets
CBOE
$31.2B
| $19.2M | 1.27% |
153,163
+16,298
| +12% | +$2.01M |
|
34
SolarEdge
SEDG
$2.1B
| $16.8M | 1.11% |
59,358
-7,661
| -11% | -$2.03M |
|
35
Kroger
KR
$35.9B
| $16.6M | 1.1% |
373,023
-3,396
| -0.9% | -$156K |
|
36
Consolidated Edison
ED
$39.7B
| $16.5M | 1.09% |
172,918
-87,123
| -34% | -$7.93M |
|
37
McCormick & Company Non-Voting
MKC
$14B
| $15.9M | 1.05% |
191,824
+36,598
| +24% | +$2.95M |
|
38
DaVita
DVA
$11.7B
| $15.3M | 1.01% |
204,568
-2,722
| -1% | -$211K |
|
39
Regeneron Pharmaceuticals
REGN
$85.2B
| $14.7M | 0.97% |
20,306
+6,251
| +44% | +$4.61M |
|
40
CF Industries
CF
$20.2B
| $14.4M | 0.96% |
169,335
+18,531
| +12% | +$1.88M |
|
41
EPAM Systems
EPAM
$6.04B
| $13.5M | 0.89% |
41,187
+3,427
| +9% | +$1.17M |
|
42
Occidental Petroleum
OXY
$60B
| $13.4M | 0.89% |
212,315
+61,254
| +41% | +$4.17M |
|
43
Gilead Sciences
GILD
$187B
| $13.2M | 0.87% |
153,843
-59,844
| -28% | -$4.74M |
|
44
Conagra Brands
CAG
$7.43B
| $13.1M | 0.86% |
337,403
-69
| -0% | -$2.5K |
|
|
45
Eversource Energy
ES
$26.8B
| $13M | 0.86% |
155,211
-134,887
| -46% | -$10.7M |
|
46
Snap
SNAP
$9.25B
| $11.8M | 0.78% |
1,317,497
+136,791
| +12% | +$1.35M |
|
47
EOG Resources
EOG
$76.2B
| $11.3M | 0.75% |
87,343
-60,774
| -41% | -$8.08M |
|
48
argenx
ARGX
$64.6B
| $11.2M | 0.74% |
29,466
+12,027
| +69% | +$4.5M |
|
49
Rogers Communications
RCI
$20.3B
| $10.8M | 0.71% |
229,798
-9,908
| -4% | -$422K |
|
|
50
Becton Dickinson
BDX
$50.3B
| $10.4M | 0.69% |
40,897
-78,807
| -66% | -$18.6M |
|
Similar funds
EC
WIP
KP
MP
AWP
THCM
PA
HP
TOBAM's Q4 2022 Portfolio in Review
As of Q4 2022, TOBAM held 456 positions worth $1.51B, up 5.6% from $1.43B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TOBAM withdrew a net $58.7M in Q4 2022, closing 50 positions and reducing 145 holdings. Its most notable exit was Electronic Arts, an estimated $18.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 31% a quarter earlier, followed by Consumer Staples and Technology.
Against the trend, TOBAM opened a new position in Enerplus Corporation worth $654K.
- TOBAM's largest Q4 2022 buy was Enerplus Corporation: 36,977 shares worth $654K.
- TOBAM added most to United Therapeutics in Q4 2022, an estimated $17.1M increase.
- TOBAM's biggest Q4 2022 reduction was Becton Dickinson, cutting an estimated $18.6M.
- TOBAM fully exited Electronic Arts in Q4 2022, selling an estimated $18.8M.
- TOBAM's ten largest holdings make up 27% of its $1.51B portfolio in Q4 2022.
- TOBAM opened 26 new positions and closed 50 in Q4 2022.
- TOBAM's portfolio value rose 5.6% quarter-over-quarter to $1.51B.
Based on TOBAM's 13F filing for Q4 2022, filed 2 Feb 2023.